Atrial Fibrillation and Percutaneous Coronary Intervention : A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting

This book considers paradigmatic clinical cases in order to cast light on key issues relating to elective or emergency stent implantation and the use of oral anticoagulation (OAC) in patients with atrial fibrillation. The topics addressed include the optimal periprocedural antithrombotic treatment (...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Rubboli, Andrea. (Editor), Lip, Gregory Y. H. (Editor)
Format: eBook
Language: English
Published: Cham : Springer International Publishing : Imprint: Springer, 2017.
Subjects:
Medicine.
Critical care medicine.
Angiology.
Cardiology.
Cardiac surgery.
Pharmacotherapy.
elektronické knihy
electronic books
ISBN: 9783319424002
Physical Description: VIII, 212 p. 52 illus., 30 illus. in color. online resource.

Cover

Table of contents

LEADER 04456nam a22004215i 4500
001 101431
003 CZ-ZlUTB
005 20240914113414.0
006 m o d
007 cr nn 008mamaa
008 161201s2017 gw | s |||| 0|eng d
020 |a 9783319424002 
024 7 |a 10.1007/978-3-319-42400-2  |2 doi 
245 1 0 |a Atrial Fibrillation and Percutaneous Coronary Intervention :  |b A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting /  |c edited by Andrea Rubboli, Gregory Y. H. Lip. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a VIII, 212 p. 52 illus., 30 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
505 0 |a Atrial fibrillation on vitamin K-antagonists undergoing elective coronary artery stenting for stable effort angina -- Atrial fibrillation on NOAC (dabigatran) undergoing elective coronary artery stenting for stable effort angina -- Atrial fibrillation on vitamin K-antagonist undergoing urgent coronary stenting for non ST-elevation acute coronary syndrome -- Atrial fibrillation on NOAC (rivaroxaban) undergoing urgent coronary stenting for non ST-elevation acute coronary syndrome -- Atrial fibrillation on vitamin K-antagonist undergoing emergency primary coronary stenting for ST-elevation acute myocardial infarction -- Atrial fibrillation on NOAC (apixaban) undergoing emergency primary coronary stenting for ST-elevation acute myocardial infarction -- Atrial fibrillation early complicating acute coronary syndrome treated with coronary artery stenting -- New-onset atrial fibrillation in a stable patient with remote coronary artery stenting -- Urgent surgery early after coronary stenting in a patient with atrial fibrillation on triple therapy of warfarin, aspirin and clopidogrel -- Urgent surgery early after coronary stenting in a patjent with atrial fibrillation on triple therapy of NOAC (a factor Xa-inhibitor), aspirin and clopidogrel -- Major bleeding early after coronary stenting in a patient with atrial fibrillation on triple therapy of warfarin, aspirin and clopidogrel -- Major bleeding early after coronary stenting in a patient with atrial fibrillation on triple therapy of NOAC (dabigatran), aspirin and clopidogrel. 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a This book considers paradigmatic clinical cases in order to cast light on key issues relating to elective or emergency stent implantation and the use of oral anticoagulation (OAC) in patients with atrial fibrillation. The topics addressed include the optimal periprocedural antithrombotic treatment (uninterrupted vs interrupted OAC, intraprocedural use of heparin and glycoprotein IIb/IIIa inhibitors, etc.), the most appropriate type of stent (bare metal vs drug eluting vs "bioactive"), the optimal regimen (e.g., triple therapy of OAC, aspirin, and clopidogrel vs the combination of OAC and a single antiplatelet agent), and the most suitable duration of the antithrombotic treatment prescribed at discharge (1 vs 6-12 months). The case-based management recommendations will be of wide practical value in the current health care context, where percutaneous coronary intervention is available even to patients with relevant co-morbidities, such as those warranting long-term OAC, and the indications for OAC are much broader than in the past. The book will appeal especially to clinical and interventional cardiologists, internal medicine specialists, hematologists, and family physicians and will also be of interest to cardiology and internal medicine residents and fellows. 
650 0 |a Medicine. 
650 0 |a Critical care medicine. 
650 0 |a Angiology. 
650 0 |a Cardiology. 
650 0 |a Cardiac surgery. 
650 0 |a Pharmacotherapy. 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 9 |a electronic books  |2 eczenas 
700 1 |a Rubboli, Andrea.  |e editor. 
700 1 |a Lip, Gregory Y. H.  |e editor. 
710 2 |a SpringerLink (Online service) 
776 0 8 |i Printed edition:  |z 9783319423982 
856 4 0 |u https://proxy.k.utb.cz/login?url=http://dx.doi.org/10.1007/978-3-319-42400-2  |y Plný text 
992 |c NTK-SpringerMED 
999 |c 101431  |d 101431 
993 |x NEPOSILAT  |y EIZ 

Similar Items